Home / SLDB : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SLDB make money? Does SLDB have pricing power? What's the Earnings Whisper? Will SLDB profit more as the business scales? What is SLDB's management track record? Is SLDB's current price justified?

Solid Biosciences Inc.

$8.94 +$3.49 (+63.94%)

NASDAQ · 14 Sep 2026 17:32 UTC

Previous Close

$8.7

Day Range

$8.72$9.11

Year Range

$3.79$11.45

Market Cap

879.65M

AVG Volume

1.45M

Trailing/Forward PE

-4.66/-

PEG ratio

5.93

Dividend Yield

Next Earnings Date

2026-11-02

Primary Exchange

NASDAQ

Revenue (USD) · TTM

SLDB Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD) · TTM

SLDB Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-207.1M
26 Q1	-191.78M
25 Q4	-174.32M
25 Q3	-167.13M
25 Q2	-154.08M
25 Q1	-139.68M
24 Q4	-124.7M
24 Q3	-102.44M
24 Q2	-90.69M
24 Q1	-90.25M

Operating Income (USD) · TTM

SLDB Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-212.15M
26 Q1	-196.46M
25 Q4	-179.21M
25 Q3	-169.7M
25 Q2	-156.82M
25 Q1	-142.92M
24 Q4	-129.73M
24 Q3	-112.1M
24 Q2	-100.03M
24 Q1	-99.08M

EBITDA (USD) · TTM

SLDB EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-205.07M
26 Q1	-190.1M
25 Q4	-172.56M
25 Q3	-165.28M
25 Q2	-152.11M
25 Q1	-136.83M
24 Q4	-121.9M
24 Q3	-99.99M
24 Q2	-88.04M
24 Q1	-88.11M

Cash Flows (USD) · TTM

SLDB Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-187.81M
26 Q1	-172.86M
25 Q4	-157.44M
25 Q3	-133.17M
25 Q2	-123.34M
25 Q1	-107.3M
24 Q4	-100.67M
24 Q3	-91.73M
24 Q2	-86.29M
24 Q1	-92.53M

EPS (USD) · TTM

SLDB EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-1.91
26 Q1	-1.95
25 Q4	-2.02
25 Q3	-2.29
25 Q2	-2.6
25 Q1	-2.79
24 Q4	-2.84
24 Q3	-2.74
24 Q2	-3
24 Q1	-3.64

Expenses (USD) · TTM

SLDB Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	213.12M
26 Q1	197.65M
25 Q4	180.36M
25 Q3	170.49M
25 Q2	157.54M
25 Q1	143.55M
24 Q4	130.38M
24 Q3	112.64M
24 Q2	100.94M
24 Q1	100.31M

Shares Outstanding (USD) · TTM

SLDB Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-8.31M
26 Q1	-5.83M
25 Q4	-16.89M
25 Q3	-14.21M
25 Q2	-8.17M
25 Q1	-7.12M
24 Q4	-5.41M
24 Q3	-3.52M
24 Q2	-7.27M
24 Q1	-7.12M

Employee Count

SLDB Employee Count by quarter
Period	Employee Count
2025	121
2024	100
2023	88
2022	87
2021	104
2020	70
2019	121
2018	111
2017	60

Free Cash Flow Yield

SLDB Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-15.02%
Sep 26	-12.75%
Aug 26	-13.38%
Aug 26	-14.05%
Aug 26	-14.21%
Aug 26	-15.58%
Jul 26	-19.53%
Jul 26	-20.1%
Jul 26	-18.05%
Jul 26	-15.11%
Jul 26	-14.52%
Jun 26	-16.94%
Jun 26	-18.9%
Jun 26	-22.05%
Jun 26	-23.49%
May 26	-21.45%
May 26	-23.78%
May 26	-22.75%
May 26	-22.86%
May 26	-23.31%
Apr 26	-20.98%
Apr 26	-19.26%
Apr 26	-20.72%
Apr 26	-22.19%
Mar 26	-23.38%
Mar 26	-23.64%
Mar 26	-19.29%
Mar 26	-20.9%
Feb 26	-22.71%
Feb 26	-24.7%
Feb 26	-22.79%
Feb 26	-21.63%
Jan 26	-21.83%
Jan 26	-21.37%
Jan 26	-25.79%
Jan 26	-26.66%
Jan 26	-25.88%
Dec 25	-24.15%
Dec 25	-23.75%
Dec 25	-24.03%
Dec 25	-24.44%
Nov 25	-25.98%
Nov 25	-30.01%
Nov 25	-33.27%
Nov 25	-34.74%
Oct 25	-24.31%
Oct 25	-23.31%
Oct 25	-22.28%
Oct 25	-21.98%
Oct 25	-22.21%
Sep 25	-21.3%
Sep 25	-25.59%
Sep 25	-24.31%
Sep 25	-23.82%
Aug 25	-23.91%
Aug 25	-22.09%
Aug 25	-21.44%
Aug 25	-25.71%
Aug 25	-23.68%
Jul 25	-23.11%
Jul 25	-25.31%
Jul 25	-30.75%
Jul 25	-32.16%
Jun 25	-34.27%
Jun 25	-33.77%
Jun 25	-35.86%
Jun 25	-35.63%
May 25	-50.39%
May 25	-57.56%
May 25	-58.39%
May 25	-68.07%
May 25	-43.59%
Apr 25	-56.93%
Apr 25	-73.68%
Apr 25	-69.59%
Apr 25	-60.22%
Mar 25	-43.49%
Mar 25	-40.84%
Mar 25	-36.91%
Mar 25	-34.66%
Feb 25	-39.6%
Feb 25	-38.29%
Feb 25	-54.92%
Feb 25	-76.85%
Jan 25	-69.6%
Jan 25	-68.95%
Jan 25	-67.69%
Jan 25	-60.15%
Jan 25	-53.46%
Dec 24	-52.2%
Dec 24	-53.21%
Dec 24	-45.08%
Dec 24	-43.83%
Nov 24	-38.83%
Nov 24	-40.91%
Nov 24	-45.64%
Nov 24	-37.71%
Nov 24	-36.66%
Oct 24	-36.92%
Oct 24	-31.94%

Price to Sales

SLDB Price to Sales by quarter
Period	Price to Sales
Aug 23	12.05
Aug 23	11.89
Jul 23	13.89
Jul 23	15.03
Jul 23	15.57
Jul 23	16.72
Jun 23	16.62
Jun 23	17.41
Jun 23	22.24
Jun 23	20.11
Jun 23	19.95
May 23	19.54
May 23	19.03
May 23	20.05
May 23	5.3
Apr 23	4.84
Apr 23	4.82
Apr 23	5.03
Apr 23	4.74
Mar 23	4.7
Mar 23	3.65
Mar 23	2.75
Mar 23	3.29
Mar 23	3.55
Feb 23	4.02
Feb 23	4.64
Feb 23	4.66
Feb 23	5.12
Jan 23	5.12
Jan 23	4.91
Jan 23	4.52
Jan 23	3.92
Dec 22	3.6
Dec 22	3.78
Dec 22	4.39
Dec 22	4.23
Dec 22	4.53
Nov 22	4.47
Nov 22	4.59
Nov 22	4.43
Nov 22	3.11
Oct 22	3.11
Oct 22	3.41
Oct 22	3.48
Oct 22	3.66
Sep 22	3.57
Sep 22	3.92
Sep 22	4.87
Sep 22	5.11
Sep 22	4.95
Aug 22	5.57
Aug 22	6.41
Aug 22	6.11
Aug 22	7
Jul 22	6.23
Jul 22	6.46
Jul 22	6.24
Jul 22	6.06
Jul 22	5.31
Jun 22	5.37
Jun 22	5.33
Jun 22	6.28
Jun 22	5.26
May 22	5.44
May 22	5.04
May 22	4.66
May 22	4.85
Apr 22	5.16
Apr 22	6.58
Apr 22	8.51
Apr 22	9.07
Apr 22	9.96
Mar 22	10.13
Mar 22	11.5
Mar 22	11.37
Mar 22	8.08
Feb 22	9.18
Feb 22	9.98
Feb 22	11.69
Feb 22	12.23
Jan 22	12.44
Jan 22	13.73
Jan 22	15.02
Jan 22	16.95
Dec 21	18.77
Dec 21	20.49
Dec 21	21.13
Dec 21	18.88
Dec 21	18.13
Nov 21	20.12
Nov 21	21.35
Nov 21	23.06
Nov 21	25.31
Oct 21	32.22
Oct 21	32.22
Oct 21	35.71
Oct 21	36.82
Oct 21	37.45
Sep 21	42.37
Sep 21	44.44

Price to Book

SLDB Price to Book by quarter
Period	Price to Book
Sep 26	3.34
Sep 26	3.94
Aug 26	3.75
Aug 26	3.57
Aug 26	3.53
Aug 26	3.22
Jul 26	2.37
Jul 26	2.3
Jul 26	2.56
Jul 26	3.06
Jul 26	3.18
Jun 26	2.73
Jun 26	2.44
Jun 26	2.1
Jun 26	1.97
May 26	2.15
May 26	1.94
May 26	2.03
May 26	3.83
May 26	3.75
Apr 26	4.17
Apr 26	4.54
Apr 26	4.22
Apr 26	3.94
Mar 26	3.74
Mar 26	3.7
Mar 26	3.17
Mar 26	2.92
Feb 26	2.69
Feb 26	2.47
Feb 26	2.68
Feb 26	2.82
Jan 26	2.8
Jan 26	2.86
Jan 26	2.37
Jan 26	2.29
Jan 26	2.36
Dec 25	2.53
Dec 25	2.57
Dec 25	2.54
Dec 25	2.5
Nov 25	2.35
Nov 25	2.04
Nov 25	1.84
Nov 25	1.76
Oct 25	1.96
Oct 25	2.05
Oct 25	2.14
Oct 25	2.17
Oct 25	2.15
Sep 25	2.24
Sep 25	1.87
Sep 25	1.96
Sep 25	2
Aug 25	2
Aug 25	2.16
Aug 25	2.23
Aug 25	1.42
Aug 25	1.54
Jul 25	1.58
Jul 25	1.44
Jul 25	1.19
Jul 25	1.13
Jun 25	1.06
Jun 25	1.08
Jun 25	1.02
Jun 25	1.02
May 25	0.72
May 25	0.63
May 25	0.62
May 25	1.08
May 25	1.68
Apr 25	1.29
Apr 25	1
Apr 25	1.05
Apr 25	1.22
Mar 25	1.69
Mar 25	1.8
Mar 25	1.99
Mar 25	2.12
Feb 25	1.39
Feb 25	1.43
Feb 25	1
Feb 25	0.71
Jan 25	0.79
Jan 25	0.8
Jan 25	0.81
Jan 25	0.91
Jan 25	1.03
Dec 24	1.05
Dec 24	1.03
Dec 24	1.22
Dec 24	1.25
Nov 24	1.41
Nov 24	1.34
Nov 24	1.2
Nov 24	1.46
Nov 24	1.22
Oct 24	1.21
Oct 24	1.4

No video analysis for this stock yet. Request one from our team.

News: SLDB

seekingalpha.com · 10 Sep 2026

Solid Biosciences Inc. (SLDB) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

globenewswire.com · 2 Sep 2026

Solid Biosciences to Participate at Upcoming Investor Conferences

CHARLESTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 2026 Cantor Global Healthcare Conference Bo Cumbo, President and CEO, and Gabriel Books, M.D.

seekingalpha.com · 2 Jul 2026

Solid Biosciences: The Bull Case Is No Longer Just Duchenne

Solid Biosciences is transitioning from a speculative Duchenne gene therapy play to a multi-asset rare disease platform with clinical validation momentum. SLDB's $380.7M cash position funds operations into 2028, supporting high-cost Phase 3 SGT-003 trials and multiple pipeline programs without near-term dilution risk. SGT-003's Phase 1/2 data show strong microdystrophin expression and safety, while additional programs in Friedreich's ataxia and CPVT expand addressable markets.